Opus Genetics, Inc. Debt Related Commitment Fees and Debt Issuance Costs
Opus Genetics, Inc. (IRD) reported Debt Related Commitment Fees and Debt Issuance Costs of $552.63 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2019-03-07
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2017-12-31 was $219.58K.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2017-06-30 was $333.05K.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2016-12-31 was $0.00.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for fiscal 2017 was $552.63K, a 76.51% increase from fiscal 2016.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for fiscal 2016 was $313.09K, a 48.30% increase from fiscal 2015.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for fiscal 2015 was $211.12K, a 2.40% increase from fiscal 2014.
- Opus Genetics, Inc. debt related commitment fees and debt issuance costs for fiscal 2014 was $206.17K, a 0.96% increase from fiscal 2013.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 6 month | Debt Related Commitment Fees and Debt Issuance Costs 9 month | Debt Related Commitment Fees and Debt Issuance Costs 12 month | Debt Related Commitment Fees and Debt Issuance Costs 132 month | Debt Related Commitment Fees and Debt Issuance Costs 135 month | Debt Related Commitment Fees and Debt Issuance Costs 138 month | Debt Related Commitment Fees and Debt Issuance Costs 141 month | Debt Related Commitment Fees and Debt Issuance Costs 144 month | Debt Related Commitment Fees and Debt Issuance Costs 147 month | Debt Related Commitment Fees and Debt Issuance Costs 150 month | Debt Related Commitment Fees and Debt Issuance Costs 153 month | Debt Related Commitment Fees and Debt Issuance Costs 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $219.58K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $219.58K derived: sum of 2 quarters · filed 2019-03-07 | $552.63K derived: sum of 3 quarters · filed 2019-03-07 | $552.63K 10-K · filed 2019-03-07 | |||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $333.05K derived: sum of 2 quarters · filed 2018-11-02 | $333.05K 10-Q · filed 2018-11-02 | ||||||||||
| 2017-06-30 | $333.05K 10-Q · filed 2018-08-03 | $333.05K 10-Q · filed 2018-08-03 | |||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $143.20K derived: sum of 2 quarters · filed 2018-03-09 | $143.20K derived: sum of 3 quarters · filed 2018-03-09 | $313.09K 10-K · filed 2018-03-09 | |||||||||
| 2016-09-30 | $143.20K 10-Q · filed 2017-11-03 | $143.20K derived: sum of 2 quarters · filed 2017-11-03 | $313.09K 10-Q · filed 2017-11-03 | ||||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $169.89K 10-Q · filed 2017-08-04 | |||||||||||
| 2016-03-31 | $169.89K 10-Q · filed 2017-05-03 | ||||||||||||
| 2015-12-31 | $211.12K 10-K · filed 2018-03-09 | ||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $206.17K 10-K · filed 2017-02-24 | |||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $206.17K 10-Q · filed 2015-11-02 | $297.82K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $206.17K 10-Q · filed 2015-08-07 | $297.82K derived: sum of 3 quarters · filed 2016-03-14 | $410.38K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-03-31 | $206.17K 10-Q · filed 2015-05-08 | $297.82K derived: sum of 2 quarters · filed 2016-03-14 | $410.38K derived: sum of 3 quarters · filed 2016-03-14 | $410.38K derived: sum of 4 quarters · filed 2016-03-14 | $1.38M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $91.65K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $204.21K derived: sum of 2 quarters · filed 2016-03-14 | $204.21K derived: sum of 3 quarters · filed 2016-03-14 | $204.21K 10-K · filed 2016-03-14 | $1.18M 10-K · filed 2014-03-21 | ||||||||
| 2013-09-30 | $112.56K 10-Q · filed 2014-11-12 | $112.56K derived: sum of 2 quarters · filed 2014-11-12 | $112.56K 10-Q · filed 2014-11-12 | $444.67K derived: sum of 4 quarters · filed 2014-11-12 | $1.08M 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | $0.00 derived: 10-Q 147 month − 10-Q 144 month · filed 2013-08-12 | $0.00 derived: sum of 2 quarters · filed 2013-08-12 | $332.11K derived: sum of 3 quarters · filed 2013-08-12 | $332.11K derived: sum of 4 quarters · filed 2013-08-12 | $972.13K 10-Q · filed 2013-08-12 | ||||||||
| 2013-03-31 | $0.00 derived: 10-Q 144 month − 10-K 141 month · filed 2013-05-09 | $332.11K derived: sum of 2 quarters · filed 2013-05-09 | $332.11K derived: sum of 3 quarters · filed 2013-05-09 | $332.11K derived: sum of 4 quarters · filed 2013-05-09 | $972.13K 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $332.11K derived: 10-K 141 month − 10-Q 138 month · filed 2013-03-22 | $332.11K derived: sum of 2 quarters · filed 2013-03-22 | $332.11K derived: sum of 3 quarters · filed 2013-03-22 | $332.11K 10-K · filed 2014-03-21 | $972.13K 10-K · filed 2013-03-22 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 138 month − 10-Q 135 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $640.02K 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 135 month − 10-Q 132 month · filed 2012-08-08 | $0.00 derived: sum of 2 quarters · filed 2012-08-08 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $640.02K 10-Q · filed 2012-08-08 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $640.02K 10-Q · filed 2012-05-09 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $97.67K 10-K · filed 2013-03-22 | |||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-09 | $0.00 derived: sum of 2 quarters · filed 2011-11-09 | $97.67K 10-Q · filed 2012-11-08 | $97.67K derived: sum of 4 quarters · filed 2012-05-09 | |||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | $97.67K 10-Q · filed 2012-08-08 | $97.67K derived: sum of 3 quarters · filed 2012-05-09 | $97.67K derived: sum of 4 quarters · filed 2012-05-09 | |||||||||
| 2011-03-31 | $97.67K 10-Q · filed 2012-05-09 | $97.67K derived: sum of 2 quarters · filed 2012-05-09 | $97.67K derived: sum of 3 quarters · filed 2012-05-09 | $277.75K derived: sum of 4 quarters · filed 2012-05-09 | |||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $0.00 derived: sum of 2 quarters · filed 2012-03-16 | $180.08K derived: sum of 3 quarters · filed 2012-03-16 | $180.08K 10-K · filed 2012-03-16 | |||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-09 | $180.08K derived: sum of 2 quarters · filed 2011-11-09 | $180.08K 10-Q · filed 2011-11-09 | ||||||||||
| 2010-06-30 | $180.08K 10-Q · filed 2011-08-09 | $180.08K 10-Q · filed 2011-08-09 | |||||||||||
| 2009-12-31 | $223.95K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |